Dendreon Corp DNDN.O reported a quarterly loss versus a year-ago profit on Monday as revenue fell and restructuring costs weighed on the biotechnology company.
The fourth-quarter loss was $38.7 million, or 26 cents per share, compared with a profit of $38.1 million, or 26 cents per share.
Excluding items, the loss was 26 cents per share. On that basis, analysts on average were expecting a loss of 56 cents per share, according to Thomson Reuters I/B/E/S.
Quarterly revenue fell to $85.5 million from $202.1 million a year ago.
(Reporting by Debra Sherman; Editing by Jeffrey Benkoe and Maureen Bavdek)